Skip to search formSkip to main contentSkip to account menu

HDACi 109

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

RG2833

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma
2018
2018
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
BackgroundMultiple myeloma (MM) is the second most common hematologic malignancy. Aberrant epigenetic modifications have been… 
Highly Cited
2015
Highly Cited
2015
Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer.
A strategy to develop chemotherapeutic agents by combining several active groups into a single molecule as a conjugate that can… 
2013
2013
Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes
Microbial infections are hypothesized to play a key role in the mechanism leading to type 1 diabetes (T1D). We used the LEW1.WR1… 
Highly Cited
2011
Highly Cited
2011
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
Histone deacetylase inhibitor (HDACI)-induced thrombocytopenia (TCP) is a major dose-limiting toxicity of this new class of drugs… 
2008
2008
Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.
Histone deacetylase inhibitors (HDACIs) are involved in cell growth, apoptosis and differentiation. This study aimed to… 
Highly Cited
2007
Highly Cited
2007
Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Histone deacetylase inhibitors (HDACIs) can inhibit proliferation, induce cell cycle arrest and stimulate apoptosis of cancer… 
2006
2006
A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Histone deacetylase inhibitors (HDACIs) can inhibit cell proliferation, induce cell cycle arrest, and stimulate the apoptosis of… 
2006
2006
RETRACTED: M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells
Highly Cited
2005
Highly Cited
2005
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors
A chimeric protein, EWS‐Fli1, identified in most Ewing's family tumors (EFTs) has been shown to be associated with the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)